DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
André Scheen
Topics & Concepts
Dipeptidyl peptidase-4Observational studyMedicineDiabetes mellitusCoronavirusCytokine stormPopulationIntensive care medicineImmunologyDiseaseCoronavirus disease 2019 (COVID-19)Type 2 diabetesInternal medicineInfectious disease (medical specialty)EndocrinologyEnvironmental healthPeptidase Inhibition and AnalysisDiabetes Treatment and ManagementCOVID-19 Clinical Research Studies